Motor Complications of Dopaminergic Medications in Parkinson's Disease.

about

Motor Complications of Dopaminergic Medications in Parkinson's Disease.

Item

http://www.wikidata.org/entity/Q55279095

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Motor Complications of Dopaminergic Medications in Parkinson's Disease.

@en

Motor Complications of Dopaminergic Medications in Parkinson's Disease.

@nl

type

Item

label

Motor Complications of Dopaminergic Medications in Parkinson's Disease.

@en

Motor Complications of Dopaminergic Medications in Parkinson's Disease.

@nl

prefLabel

Motor Complications of Dopaminergic Medications in Parkinson's Disease.

@en

Motor Complications of Dopaminergic Medications in Parkinson's Disease.

@nl

P1476

Motor Complications of Dopaminergic Medications in Parkinson's Disease.

@en

P2093

Christopher W Hess

http://www.w3.org/2001/XMLSchema#string

Maria Eliza Freitas

http://www.w3.org/2001/XMLSchema#string

P2860

Eradication of Helicobacter pylori infection improves levodopa action, clinical symptoms and quality of life in patients with Parkinson's disease

Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson´s disease patients with motor complications

Association between Parkinson's Disease and Helicobacter Pylori

Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson's disease: a dose-finding study.

Levodopa-induced dyskinesias in Parkinson's disease: clinical and pharmacological classification

Early development of levodopa-induced dyskinesias and response fluctuations in young-onset Parkinson's disease

Dopamine D2 receptor gene polymorphism and the risk of levodopa-induced dyskinesias in PD

From off-period dystonia to peak-dose chorea. The clinical spectrum of varying subthalamic nucleus activity

Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study

P304

147-157

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1055/S-0037-1602423

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Susan H Fox

P577

2017-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28511255

http://www.w3.org/2001/XMLSchema#string

P921

dopamine

P932

5990008

http://www.w3.org/2001/XMLSchema#string